Pancreatic Cancer Research

ResearcherKyoto Prefectural University of MedicineActive in the last 2 years

Hidemasa Kubo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7294-5148; OpenAlex author ID A5083391091. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Rising Pancreatic Cancer Incidence in Young Japanese Women and Increasing Distal Pancreatectomy in Older Adults: A Nationwide Claims-Based Analysis From 2016 t… Co-author DOI 10.1002/ags3.70178↗
  2. [Resection of Borderline Resectable Pancreatic Cancer with Arterial Involvement Following a Marked Response to Neoadjuvant Chemotherapy-A Case Report]. First author PMID 42723240↗
  3. Impact of Perioperative Hemoglobin A1c Levels on Survival Outcomes of Patients With Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1097/as9.0000000000000597↗
  4. Corrigendum to Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer: [Surgery. 2022;172(6):1776-81, DOI: 10… Co-author DOI 10.1016/j.surg.2023.05.001↗
  5. Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer. Co-author DOI 10.1016/j.surg.2022.09.025↗
  6. The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Ven… Co-author DOI 10.1245/s10434-022-11628-8↗
  7. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated … Co-author DOI 10.1245/s10434-022-11662-6↗
  8. Photodynamic diagnosis of peritoneal metastasis in human pancreatic cancer using 5-aminolevulinic acid during staging laparoscopy. Co-author DOI 10.3892/ol.2018.8732↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mihoko Yamada · 5 shared papers, 2022–2025 · strength 0.87
  2. Teiichi Sugiura · 5 shared papers, 2022–2025 · strength 0.87
  3. Ryo Ashida · 5 shared papers, 2022–2025 · strength 0.87
  4. Katsuhiko Uesaka · 5 shared papers, 2022–2025 · strength 0.87
  5. Katsuhisa Ohgi · 5 shared papers, 2022–2025 · strength 0.87
  6. Ryo Morimura · 3 shared papers, 2018–2026 · strength 0.60
  7. Taisuke Imamura · 2 shared papers, 2026 · strength 0.52
  8. Atsushi Shiozaki · 2 shared papers, 2026 · strength 0.52
  9. Tomoko Norose · 2 shared papers, 2022–2023 · strength 0.33
  10. Kentaro Yamazaki · 2 shared papers, 2022 · strength 0.30
  11. Akiko Todaka · 2 shared papers, 2022 · strength 0.30
  12. Masamitsu Kido · 1 shared paper, 2026 · strength 0.28
  13. Goshi Takayama · 1 shared paper, 2026 · strength 0.24
  14. Yoshiyasu Kato · 1 shared paper, 2025 · strength 0.24
  15. Kyoichi Harada · 1 shared paper, 2018 · strength 0.08
  16. Eigo Otsuji · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.